MedTrace Logo

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

NCT02984761 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 670

Last updated 2026-02-19

No results posted yet for this study

Summary

Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments and are therefore conducting this study to determine if one may be possibly better than the other.

Conditions

  • Lung Neoplasm

Interventions

RADIATION

Stereotactic Radiotherapy

Stereotactic radiotherapy uses high doses of ionizing energy to treat cancer cells with image guidance. The treatment is delivered in an outpatient setting, and for purposes of this trial is delivered in 3-5 fractions.

PROCEDURE

Anatomic Pulmonary Resection

An anatomic pulmonary resection is an oncologic procedure that dissects out an anatomically defined segment of the lung to remove all of the lung tissue around a lung tumor. It requires an operation with general anesthesia, with a short hospital stay. The procedure entails removal of lymph nodes inside the chest that might not be easily accessible without an operation.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Drew Moghanaki, MD MPH · VA Greater Los Angeles Healthcare System, West Los Angeles, CA

  • David H Harpole, MD · Durham VA Medical Center, Durham, NC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-13
Primary Completion
2032-09-30
Completion
2034-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02984761 on ClinicalTrials.gov